Tatjana Tasic

Tatjana Tasic

Auto-generated profile, based on publicly available information

Tatjana Tasic

School of Dental Medicine, University of Belgrade, Serbia (T.T.).

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2022 in Circulation Research
Verified
Journal Article
Open access
PDF file
APAudrys G. Pauza
Audrys G. Pauza
PTPratik Thakkar
Pratik Thakkar
TTTatjana Tasic
Tatjana Tasic
IFIgor Felippe
Igor Felippe
PBPaul Bishop
Paul Bishop
DMDavid Murphy
David Murphy
Background: Aberrant sympathetic nerve activity exacerbates cardiovascular risk in hypertension and diabetes, which are common comorbidities, yet clinically sympathetic nerve activity remains poorly controlled. The hypertensive diabetic state is associated with increased reflex sensitivity and tonic drive from the peripheral chemoreceptors, the cause of which is unknown. We have previously shown hypertension to be critically dependent on the carotid body (CB) input in spontaneously hypertensive rat, a model that also exhibits a number of diabetic traits. CB overstimulation by insulin and leptin has been similarly implicated in the development of increased sympathetic nerve activity in metabolic syndrome and obesity. Thus, we hypothesized that in hypertensive diabetic state (spontaneously hypertensive rat), the CB is sensitized by altered metabolic signaling causing excessive sympathetic activity levels and dysfunctional reflex regulation. Methods: Using a hypothesis-free RNA-seq approach, we investigated potential molecular targets implicated in energy metabolism mediating CB sensitization and its regulation of sympathetic outflow in experimental hypertension. Identified targets were characterized using molecular and functional techniques assessing peripheral chemoreflex sensitivity in situ and in vivo. Results: We discovered GLP1R (glucagon-like peptide-1 receptor) expression in the CBs of rat and human and showed that its decreased expression is linked to sympathetic hyperactivity in rats with cardiometabolic disease. We demonstrate GLP1R to be localized to CB chemosensory cells, while targeted administration of GLP1R agonist to the CB lowered its basal discharge and attenuated chemoreflex-evoked blood pressure and sympathetic responses. Importantly, hyperglycemia-induced peripheral chemoreflex sensitization and associated basal sympathetic overactivity were abolished by GLP1R activation in the CB suggesting a role in a homeostatic response to high blood glucose. Conclusions: We show that GLP1 (glucagon-like peptide-1) modulates the peripheral chemoreflex acting on the CB, supporting this organ as a multimodal receptor. Our findings pinpoint CBs as potential targets for ameliorating excessive sympathetic activity using GLP1R agonists in the hypertensive-diabetic condition.

1 January 2025
Verified
Conference Paper
Closed access
MJMirjana Jovanovic
Mirjana Jovanovic
BSBojana Stevanovic
Bojana Stevanovic
VPVladislav Pajović
Vladislav Pajović
TTTatjana Tasic
Tatjana Tasic
MLMaja Lozic
Maja Lozic
UBUniversity of Belgrade
University of Belgrade
Cardiovascular system (CVS) adaptation during pregnancy involves numerous hemodynamic changes and remodeling of peripheral and central regulatory mechanisms. A decrease in blood pressure (BP) during pregnancy activates the baroreflex, leading to an increase in sympathetic tone and the synthesis and secretion of vasopressin (VP). It is well-established that VP plays a critical role in the adaptation to normotensive pregnancy, as well as in the development of primary hypertension. However, the effects of VP on neuroendocrine and autonomic adaptation of the CVS in the context of chronic hypertension during pregnancy remain insufficiently studied. This study was conducted on normotensive Wistar (WR) and spontaneously hypertensive rats (SHR) implanted with radiotelemetry devices for continuous hemodynamic measurements. BP and heart rate (HR) variability were assessed through spectral analysis, while baroreflex sensitivity (BRS) was measured using the sequence method. Plasma VP concentration was measured by ELISA, and gene expression of VP, V1aR, and V1bR was analyzed via RT-qPCR. The results indicate that non-pregnant SHR females exhibit higher gene expression of VP, V1aR, and V1bR in the paraventricular nucleus (PVN) and supraoptic nucleus (SON) compared to WR females in diestrus. Pregnant SHR females show reduced VP expression in the SON, lower plasma VP concentrations, and normalized BP during late pregnancy, but also exhibit signs of increased sympathetic cardiac stimulation (elevated HR and LF-HR), as well as activation of vagal mechanisms (increased BRS and HF-HR). In WR females, late pregnancy induces increased gene expression of VP in the PVN and SON, while changes in plasma VP levels and BP are less pronounced, as are alterations in autonomic control. These findings indicate differences in adaptation between WR and SHR females.